Assembly Biosciences (ASMB) Current Leases (2019 - 2026)
Assembly Biosciences (ASMB) posted quarterly Current Leases of $590000.0 for Q1 2026, up 11.53% year-over-year from $529000.0 in Q1 2025, and up 3.69% quarter-over-quarter from $569000.0 in Q4 2025.
Assembly Biosciences (ASMB) Current Leases (2019 - 2026) Analysis & Trends
Assembly Biosciences' Current Leases history runs 8 years deep, the most recent figure standing at $590000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 11.53% year-over-year to $590000.0; the TTM figure through Mar 2026 stood at $590000.0 (up 11.53% YoY), while the FY2025 annual figure was $569000.0, up 23.43% from the prior year.
- Current Leases for Q1 2026 stood at $590000.0, up from $569000.0 in the prior quarter.
- The five-year high for Current Leases was $3.4 million in Q3 2022, with the low at $461000.0 in Q4 2024.
- The 5-year median for Current Leases is $1.2 million (2023), against an average of $1.6 million.
- The sharpest annual moves came in 2023 and 2024: Current Leases sank 74.22% in 2023, then surged 52.93% in 2024.
- Assembly Biosciences' Current Leases stood at $3.4 million in 2022, then plunged by 63.73% to $1.2 million in 2023, then tumbled by 62.21% to $461000.0 in 2024, then rose by 23.43% to $569000.0 in 2025, then increased by 3.69% to $590000.0 in 2026.
- Business Quant data shows ASMB's Current Leases at $590000.0 in Q1 2026, $569000.0 in Q4 2025, and $548000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Assembly Biosciences | 670.88 Mn | 350.52 Mn | - | 612,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 612,000.00 |
| Mar 31, 2026 | 590,000.00 |
| Dec 31, 2025 | 569,000.00 |
| Sep 30, 2025 | 548,000.00 |
| Jun 30, 2025 | 533,000.00 |
| Mar 31, 2025 | 529,000.00 |
| Dec 31, 2024 | 461,000.00 |
| Sep 30, 2024 | 1.33 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 1.15 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | 869,000.00 |
| Jun 30, 2023 | 1.70 Mn |
| Mar 31, 2023 | 2.55 Mn |
| Dec 31, 2022 | 3.36 Mn |
| Sep 30, 2022 | 3.37 Mn |
| Jun 30, 2022 | 3.31 Mn |
| Mar 31, 2022 | 3.21 Mn |
| Dec 31, 2021 | 3.15 Mn |
| Sep 30, 2021 | 3.10 Mn |